Literature DB >> 10677505

Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells.

P G Lutz1, C Moog-Lutz, E Coumau-Gatbois, L Kobari, Y Di Gioia, Y E Cayre.   

Abstract

Hematopoiesis depends on a pool of quiescent hematopoietic stem/progenitor cells. When exposed to specific cytokines, a portion of these cells enters the cell cycle to generate an amplified progeny. Myeloblastin (MBN) initially was described as involved in proliferation of human leukemia cells. The granulocyte colony-stimulating factor (G-CSF), which stimulates the proliferation of granulocytic precursors, up-regulates MBN expression. Here we show that constitutive overexpression of MBN confers factor-independent growth to murine bone marrow-derived Ba/F3/G-CSFR cells. Our results point to MBN as a G-CSF responsive gene critical to factor-independent growth and indicate that expression of the G-CSF receptor is a prerequisite to this process. A 91-bp MBN promoter region containing PU.1, C/EBP, and c-Myb binding sites is responsive to G-CSF treatment. Although PU.1, C/EBP, and c-Myb transcription factors all were critical for expression of MBN, its up-regulation by G-CSF was associated mainly with PU.1. These findings suggest that MBN is an important target of PU.1 and a key protease for factor-independent growth of hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677505      PMCID: PMC26481          DOI: 10.1073/pnas.97.4.1601

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units.

Authors:  J J Molldrem; E Clave; Y Z Jiang; D Mavroudis; A Raptis; N Hensel; V Agarwala; A J Barrett
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

Review 2.  Regulation of immature myeloid cell differentiation by PEBP2/CBF, Myb, C/EBP and Ets family members.

Authors:  A D Friedman
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

3.  Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells.

Authors:  R Dengler; U Münstermann; S al-Batran; I Hausner; S Faderl; C Nerl; B Emmerich
Journal:  Br J Haematol       Date:  1995-02       Impact factor: 6.998

4.  Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid.

Authors:  L S Tkatch; K A Rubin; S F Ziegler; D J Tweardy
Journal:  J Leukoc Biol       Date:  1995-06       Impact factor: 4.962

5.  Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells.

Authors:  R A Steinman; D J Tweardy
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

6.  Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells.

Authors:  K Adachi; H Saito
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.

Authors:  C Labbaye; M Valtieri; T Barberi; E Meccia; B Masella; E Pelosi; G L Condorelli; U Testa; C Peschle
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M.

Authors:  M Oelgeschläger; J Krieg; J M Lüscher-Firzlaff; B Lüscher
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

9.  Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.

Authors:  C Tomasetto; C Régnier; C Moog-Lutz; M G Mattei; M P Chenard; R Lidereau; P Basset; M C Rio
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

10.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

View more
  9 in total

1.  A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.

Authors:  Clara F Burande; Mélina L Heuzé; Isabelle Lamsoul; Bernard Monsarrat; Sandrine Uttenweiler-Joseph; Pierre G Lutz
Journal:  Mol Cell Proteomics       Date:  2009-04-17       Impact factor: 5.911

2.  Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.

Authors:  Arnaud Millet; Katherine R Martin; Francis Bonnefoy; Philippe Saas; Julie Mocek; Manal Alkan; Benjamin Terrier; Anja Kerstein; Nicola Tamassia; Senthil Kumaran Satyanarayanan; Amiram Ariel; Jean-Antoine Ribeil; Loïc Guillevin; Marco A Cassatella; Antje Mueller; Nathalie Thieblemont; Peter Lamprecht; Luc Mouthon; Sylvain Perruche; Véronique Witko-Sarsat
Journal:  J Clin Invest       Date:  2015-10-05       Impact factor: 14.808

3.  Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.

Authors:  S Ohlsson; T Hellmark; K Pieters; G Sturfelt; J Wieslander; M Segelmark
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.

Authors:  K Pieters; A Pettersson; U Gullberg; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

Authors:  Han Liang; Lydia W T Cheung; Jie Li; Zhenlin Ju; Shuangxing Yu; Katherine Stemke-Hale; Turgut Dogruluk; Yiling Lu; Xiuping Liu; Chao Gu; Wei Guo; Steven E Scherer; Hannah Carter; Shannon N Westin; Mary D Dyer; Roeland G W Verhaak; Fan Zhang; Rachel Karchin; Chang-Gong Liu; Karen H Lu; Russell R Broaddus; Kenneth L Scott; Bryan T Hennessy; Gordon B Mills
Journal:  Genome Res       Date:  2012-10-01       Impact factor: 9.043

Review 6.  Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.

Authors:  Helena Crisford; Elizabeth Sapey; Robert A Stockley
Journal:  Respir Res       Date:  2018-09-20

7.  Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow.

Authors:  Kutay Karatepe; Haiyan Zhu; Xiaoyu Zhang; Rongxia Guo; Hiroto Kambara; Fabien Loison; Peng Liu; Hongbo Yu; Qian Ren; Xiao Luo; John Manis; Tao Cheng; Fengxia Ma; Yuanfu Xu; Hongbo R Luo
Journal:  Stem Cell Reports       Date:  2018-11-01       Impact factor: 7.765

8.  Analysis of VEGF-responsive genes involved in the activation of endothelial cells.

Authors:  Kishore K Wary; Geeta D Thakker; Joseph O Humtsoe; Jun Yang
Journal:  Mol Cancer       Date:  2003-07-09       Impact factor: 27.401

Review 9.  Rethinking the bile acid/gut microbiome axis in cancer.

Authors:  John P Phelan; F Jerry Reen; Jose A Caparros-Martin; Rosemary O'Connor; Fergal O'Gara
Journal:  Oncotarget       Date:  2017-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.